Range Cancer Therapeutics Index ETF CNCR
9.02 USD +0.14 (+1.58%)
At closeMay 27, 2025, 4:00 PM EDT
9.02 Day range 9.41
7.88 52-week range 16.27
- YTD
- -26.73%
- 1 year
- -34.26%
- Market cap
- 7.04M
- YTD return
- -26.73%
- 1-year return
- -34.26%
- Volume
- 3.08K
- Avg volume
- 3.41K
- Open
- 9.41
- Previous close
- 8.88
- Day's range
- 9.02 – 9.41
- 52-week range
- 7.88 – 16.27
2Y -6.57 (-42.14%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 14.25
- 200-day average
- 14.74
About Range Cancer Therapeutics Index ETF
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts (“ADRs”) with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund’s total assets will be invested in the component securities of the index.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CNCR — it syncs with the Stock Master app.